Clinical Trial Update: B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab, a B-cell depleting therapy, for fatigue in primary biliary cholangitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Fatigue, Primary Biliary Cirrhosis | Phase 2 | Status: COMPLETED